FDA Inspection 1219303 — Fast-Track Drugs and Biologics, LLC
The FDA completed an inspection of Fast-Track Drugs and Biologics, LLC on July 20, 2023 in Poolesville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 20, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Poolesville, MD (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)